UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 319

Sortiert nach

Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems

Nutrients, 2022-05, Vol.14 (9), p.1906

2022

Volltextzugriff (PDF)

Harnessing wearables and mobile phones to improve glycemic outcomes with automated insulin delivery

The Lancet. Digital health, 2023-09, Vol.5 (9), p.e548-e549

Lewis, Dana M

2023

Volltextzugriff (PDF)

Survey of Pancreatic Enzyme Replacement Therapy Dosing Experiences in Adults with Exocrine Pancreatic Insufficiency

Healthcare (Basel), 2023-08, Vol.11 (16), p.2316

2023

Volltextzugriff (PDF)

Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes

Journal of medical Internet research, 2023-12, Vol.25 (5), p.e44002-e44002

2023

Volltextzugriff (PDF)

1304-P: Exocrine Pancreatic Insufficiency (EPI) Likely Overlooked in Diabetes as Common Cause of Gastrointestinal-Related Symptoms

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

LEWIS, DANA M.

2023

Volltextzugriff (PDF)

Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement

Endocrinology and metabolism clinics of North America, 2020-03, Vol.49 (1), p.203-213

Lewis, Dana M.

2020

Volltextzugriff (PDF)

Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial

Diabetes technology & therapeutics, 2023-04, Vol.25 (4), p.250

2023

Volltextzugriff (PDF)

Long-Term Glucose Forecasting for Open-Source Automated Insulin Delivery Systems: A Machine Learning Study with Real-World Variability Analysis

Healthcare (Basel), 2023-03, Vol.11 (6), p.779

2023

Volltextzugriff (PDF)

Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems

Diabetic medicine, 2022-05, Vol.39 (5), p.e14687-n/a

Lewis, Dana M.

2022

Volltextzugriff (PDF)

Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)

Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2333-2337

2019

Volltextzugriff (PDF)

Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?

Case reports in neurology, 2022-04, Vol.14 (1), p.213-222

2022

Volltextzugriff (PDF)

Breaking a feedback loop: A reassessment of an investigator initiated OS‐AID study

Diabetes, obesity & metabolism, 2024-01, Vol.26 (1), p.400-402

2024

Volltextzugriff (PDF)

Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey

Frontiers in clinical diabetes and healthcare (online), 2022-07, Vol.3, p.876511-876511

2022

Volltextzugriff (PDF)

Open-Source Automated Insulin Delivery in Type 1 Diabetes

The New England journal of medicine, 2022-09, Vol.387 (10), p.869-881

2022

Volltextzugriff (PDF)

Continuous glucose monitoring

BMJ (Online), 2023-03, Vol.380, p.e072420

2023

Volltextzugriff (PDF)

Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes

Diabetes therapy, 2022-09, Vol.13 (9), p.1683-1699

2022

Volltextzugriff (PDF)

Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types

Digestive diseases and sciences, 2024-02, Vol.69 (2), p.615-633

2024

Volltextzugriff (PDF)

99-LB: Multiscale Biological Rhythms in Individuals with T1D on DIY Closed-Loop and SAPT

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

988-P: Do-It-Yourself Artificial Pancreas Systems for Type 1 Diabetes Reduce Hyperglycemia without Increasing Hypoglycemia

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Learning challenges of healthcare professionals supporting open‐source automated insulin delivery

Diabetic medicine, 2022-05, Vol.39 (5), p.e14750-n/a

2022

Volltextzugriff (PDF)

Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey

Diabetes research and clinical practice, 2023-03, Vol.197, p.110235-110235, Article 110235

2023

Volltextzugriff (PDF)

76-OR: In-Depth Review of Glycemic Control and Glycemic Variability in People with Type 1 Diabetes Using Open Source Artificial Pancreas Systems

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

286-OR: The CREATE Trial: Randomized Clinical Trial Comparing Open-Source Automated Insulin Delivery with Sensor Augmented Pump Therapy in Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

America's Haven of Health: Hydrotherapy and tourism at Excelsior Springs, Missouri, USA

History and anthropology, 2023-08, Vol.34 (4), p.698-725

2023

Volltextzugriff (PDF)

78-LB: Detailing the Experiences of People with Diabetes Using Do-It-Yourself Artificial Pancreas Systems—Qualitative Analysis of Responses to Open-Ended Items in an International Survey

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Journals Online

KollektionSpringer Nature - Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(288)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(316)
Japanisch
(35)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems

Harnessing wearables and mobile phones to improve glycemic outcomes with automated insulin delivery

Survey of Pancreatic Enzyme Replacement Therapy Dosing Experiences in Adults with Exocrine Pancreatic Insufficiency

Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes

1304-P: Exocrine Pancreatic Insufficiency (EPI) Likely Overlooked in Diabetes as Common Cause of Gastrointestinal-Related Symptoms

Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement

Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial

Long-Term Glucose Forecasting for Open-Source Automated Insulin Delivery Systems: A Machine Learning Study with Real-World Variability Analysis

Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems

Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)

Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?

Breaking a feedback loop: A reassessment of an investigator initiated OS‐AID study

Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey

Open-Source Automated Insulin Delivery in Type 1 Diabetes

Continuous glucose monitoring

Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes

Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types

99-LB: Multiscale Biological Rhythms in Individuals with T1D on DIY Closed-Loop and SAPT

988-P: Do-It-Yourself Artificial Pancreas Systems for Type 1 Diabetes Reduce Hyperglycemia without Increasing Hypoglycemia

Learning challenges of healthcare professionals supporting open‐source automated insulin delivery

Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey

76-OR: In-Depth Review of Glycemic Control and Glycemic Variability in People with Type 1 Diabetes Using Open Source Artificial Pancreas Systems

286-OR: The CREATE Trial: Randomized Clinical Trial Comparing Open-Source Automated Insulin Delivery with Sensor Augmented Pump Therapy in Type 1 Diabetes

America's Haven of Health: Hydrotherapy and tourism at Excelsior Springs, Missouri, USA

78-LB: Detailing the Experiences of People with Diabetes Using Do-It-Yourself Artificial Pancreas Systems—Qualitative Analysis of Responses to Open-Ended Items in an International Survey

Aktive Filter

Suchergebnisse filtern